Dutch development funds invest in dairy technology

Investors, including Rabobank partners SHIFT, are targeting Mastiline in the belief its technology could be internationally commercialised and decrease antibiotic use.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.